Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Volumetric-modulated arc therapy for left-sided breast cancer and all regional nodes improves target volumes coverage and reduces treatment time and doses to the heart and left coronary artery, compared with a field-in-field technique.
Tyran M, Mailleux H, Tallet A, Fau P, Gonzague L, Minsat M, Moureau-Zabotto L, Resbeut M. Tyran M, et al. Among authors: minsat m. J Radiat Res. 2015 Nov;56(6):927-37. doi: 10.1093/jrr/rrv052. Epub 2015 Sep 19. J Radiat Res. 2015. PMID: 26386255 Free PMC article.
Exclusive intraoperative radiotherapy for invasive breast cancer in elderly patients (>70 years): proportion of eligible patients and local recurrence-free survival.
Lambaudie E, Houvenaeghel G, Ziouèche A, Knight S, Dravet F, Garbay JR, Giard S, Charitansky H, Cohen M, Faure C, Hudry D, Azuar P, Villet R, Gimbergues P, de Lara CT, Tallet A, Bannier M, Minsat M, Resbeut M. Lambaudie E, et al. Among authors: minsat m. BMC Surg. 2016 Nov 15;16(1):74. doi: 10.1186/s12893-016-0191-9. BMC Surg. 2016. PMID: 27846840 Free PMC article.
Eligibility criteria for intraoperative radiotherapy for breast cancer: study employing 12,025 patients treated in two cohorts.
Ziouèche-Mottet A, Houvenaeghel G, Classe JM, Garbay JR, Giard S, Charitansky H, Cohen M, Belichard C, Faure C, Chéreau Ewald E, Hudry D, Azuar P, Villet R, Gimbergues P, Tunon de Lara C, Tallet A, Bannier M, Minsat M, Lambaudie E, Resbeut M. Ziouèche-Mottet A, et al. Among authors: minsat m. BMC Cancer. 2014 Nov 24;14:868. doi: 10.1186/1471-2407-14-868. BMC Cancer. 2014. PMID: 25417756 Free PMC article.
High-dose-rate vs. low-dose-rate interstitial brachytherapy boost for anal canal cancers.
Varela Cagetti L, Zemmour C, Salem N, Minsat M, Ferrè M, Mailleux H, Giovaninni M, Lelong B, De Chaisemartin C, Ries P, Poizat F, Tallet A, Moureau-Zabotto L. Varela Cagetti L, et al. Among authors: minsat m. Brachytherapy. 2019 Nov-Dec;18(6):814-822. doi: 10.1016/j.brachy.2019.08.005. Epub 2019 Sep 9. Brachytherapy. 2019. PMID: 31515067
Survival after breast cancer local recurrence according to therapeutic strategies.
Houvenaeghel G, Boher JM, Michel V, Bannier M, Minsat M, Tallet A, Cohen M, Buttarelli M, Resbeut M, Lambaudie E. Houvenaeghel G, et al. Among authors: minsat m. Eur J Surg Oncol. 2017 Aug;43(8):1409-1414. doi: 10.1016/j.ejso.2017.04.006. Epub 2017 May 4. Eur J Surg Oncol. 2017. PMID: 28536053
Anal canal cancer: management of inguinal nodes and benefit of prophylactic inguinal irradiation (CORS-03 Study).
Ortholan C, Resbeut M, Hannoun-Levi JM, Teissier E, Gerard JP, Ronchin P, Zaccariotto A, Minsat M, Benezery K, François E, Salem N, Ellis S, Azria D, Champetier C, Gross E, Cowen D. Ortholan C, et al. Among authors: minsat m. Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1988-95. doi: 10.1016/j.ijrobp.2011.02.010. Epub 2011 May 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 21570207
Is neoadjuvant chemotherapy prior to radio-chemotherapy beneficial in T4 anal carcinoma?
Moureau-Zabotto L, Viret F, Giovaninni M, Lelong B, Bories E, Delpero JR, Pesenti C, Caillol F, de Chaisemartin C, Minsat M, Monges G, Sarran A, Resbeut M. Moureau-Zabotto L, et al. Among authors: minsat m. J Surg Oncol. 2011 Jul 1;104(1):66-71. doi: 10.1002/jso.21866. Epub 2011 Jan 15. J Surg Oncol. 2011. PMID: 21240983
36 results